Company intelligence / Profile preview

Novadiscovery

Lyon, Auvergne-Rhone-Alpes, Francedebiopharm.com ↗

Ownership: Private
Employees: ~67
Development stage: Commercial

Overview

Novadiscovery’s Jinkō® platform enables biotech and pharma companies to simulate clinical trials using virtual patients (“in silico” medicine), optimizing trial design and reducing costs. The technology has demonstrated predictive power in oncology and other areas by accurately forecasting Phase III trial outcomes before real-world execution. It is used by major pharmaceutical companies such as Takeda and Janssen to de-risk R&D programs.

Industry: Drug Discovery Services

Partnerships

TakedaJanssen-Cilag France / Johnson & Johnson/JanssenENYO Pharma

Beyond the preview

Go deeper on Novadiscovery.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novadiscovery.

Explore the full profile